Lawrence Herz

2.4k total citations
35 papers, 1.9k citations indexed

About

Lawrence Herz is a scholar working on Psychiatry and Mental health, General Health Professions and Social Psychology. According to data from OpenAlex, Lawrence Herz has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 9 papers in General Health Professions and 8 papers in Social Psychology. Recurrent topics in Lawrence Herz's work include Schizophrenia research and treatment (11 papers), Mental Health Treatment and Access (8 papers) and Posttraumatic Stress Disorder Research (5 papers). Lawrence Herz is often cited by papers focused on Schizophrenia research and treatment (11 papers), Mental Health Treatment and Access (8 papers) and Posttraumatic Stress Disorder Research (5 papers). Lawrence Herz collaborates with scholars based in United States. Lawrence Herz's co-authors include Roger K. Pitman, Scott P. Orr, Natasha B. Lasko, Ladislav Volicer, Scott S. Campbell, Virginia Ross, Andrew Satlin, Donald Goff, Bruce Altman and Leslie Leahy and has published in prestigious journals such as American Journal of Psychiatry, Journal of Consulting and Clinical Psychology and Journal of Neurochemistry.

In The Last Decade

Lawrence Herz

34 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lawrence Herz United States 19 655 615 322 267 251 35 1.9k
Tommi Tolmunen Finland 33 732 1.1× 720 1.2× 225 0.7× 191 0.7× 340 1.4× 108 2.9k
Rudy Bowen Canada 29 976 1.5× 563 0.9× 212 0.7× 325 1.2× 505 2.0× 76 2.4k
M. Ansseau Belgium 23 553 0.8× 431 0.7× 298 0.9× 346 1.3× 417 1.7× 109 2.2k
Felicity Ng Australia 20 546 0.8× 885 1.4× 193 0.6× 180 0.7× 208 0.8× 40 2.7k
Jonna Perälä Finland 26 675 1.0× 1.3k 2.2× 251 0.8× 146 0.5× 228 0.9× 42 2.5k
Martin M. Katz United States 26 800 1.2× 998 1.6× 245 0.8× 259 1.0× 529 2.1× 49 2.4k
Chris C. Streeter United States 18 979 1.5× 396 0.6× 503 1.6× 408 1.5× 363 1.4× 43 2.2k
Arlette F. Buchmann Germany 28 925 1.4× 274 0.4× 257 0.8× 240 0.9× 209 0.8× 42 1.9k
Federica Vellante Italy 24 790 1.2× 638 1.0× 227 0.7× 169 0.6× 261 1.0× 57 2.0k
I Hui Lee Taiwan 24 460 0.7× 902 1.5× 481 1.5× 450 1.7× 430 1.7× 117 2.3k

Countries citing papers authored by Lawrence Herz

Since Specialization
Citations

This map shows the geographic impact of Lawrence Herz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Herz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Herz more than expected).

Fields of papers citing papers by Lawrence Herz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Herz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Herz. The network helps show where Lawrence Herz may publish in the future.

Co-authorship network of co-authors of Lawrence Herz

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Herz. A scholar is included among the top collaborators of Lawrence Herz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Herz. Lawrence Herz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Osei‐Bonsu, Princess E., et al.. (2016). Mental Health Providers’ Decision-Making Around the Implementation of Evidence-Based Treatment for PTSD. The Journal of Behavioral Health Services & Research. 44(2). 213–223. 51 indexed citations
2.
Osei‐Bonsu, Princess E., Avron Spiro, Mark Schultz, et al.. (2012). Is DSM‐IV criterion A2 associated with PTSD diagnosis and symptom severity?. Journal of Traumatic Stress. 25(4). 368–375. 13 indexed citations
3.
4.
Eisen, Susan V., Kathryn A. Bottonari, Mark E. Glickman, et al.. (2010). The Incremental Value of Self-Reported Mental Health Measures in Predicting Functional Outcomes of Veterans. The Journal of Behavioral Health Services & Research. 38(2). 170–190. 13 indexed citations
5.
Sloan, Kevin L., Maria E. Montez‐Rath, Avron Spiro, et al.. (2006). Development and Validation of a Psychiatric Case-Mix System. Medical Care. 44(6). 568–580. 27 indexed citations
6.
Ren, Xiangyu, et al.. (2006). Treatment persistence: a comparison among patients with schizophrenia who were initiated on atypical antipsychotic agents. Journal of Clinical Pharmacy and Therapeutics. 31(1). 57–65. 16 indexed citations
7.
Yu, Wei, Xinhua S. Ren, Austin F. Lee, et al.. (2006). Association of Co-Morbidities with Prescribing Patterns and Cost Savings. PharmacoEconomics. 24(12). 1233–1248. 1 indexed citations
8.
Drebing, Charles E., Christopher Krebs, Robert A. Rosenheck, et al.. (2005). THE IMPACT OF ENHANCED INCENTIVES ON VOCATIONAL REHABILITATION OUTCOMES FOR DUALLY DIAGNOSED VETERANS. Journal of Applied Behavior Analysis. 38(3). 359–372. 45 indexed citations
9.
Ren, Xinhua S., Lewis E. Kazis, Austin F. Lee, et al.. (2005). Patient characteristics and the likelihood of initiation on olanzapine or risperidone among patients with schizophrenia. Schizophrenia Research. 77(2-3). 167–177. 7 indexed citations
10.
Freudenreich, Oliver, Lawrence Herz, Thilo Deckersbach, et al.. (2005). Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial. Psychopharmacology. 181(2). 358–363. 56 indexed citations
11.
Ren, Xiangyu, et al.. (2004). Initiation of atypical antipsychotic agents and health outcomes in patients with schizophrenia. Journal of Clinical Pharmacy and Therapeutics. 29(5). 471–481. 7 indexed citations
12.
Drebing, Charles E., et al.. (2004). Documenting pathways to dementia care: Relative validity of questionnaire, interview, and medical record formats. American Journal of Alzheimer s Disease & Other Dementias®. 19(3). 187–197. 15 indexed citations
13.
Goff, Donald, Lawrence Herz, Vivian E. Shih, et al.. (2004). A six-month, placebo-controlled trial of d-cycloserine co-administered with conventional antipsychotics in schizophrenia patients. Psychopharmacology. 179(1). 144–150. 95 indexed citations
14.
Rosen, Amy K., Arlene S. Ash, Richard R. Owen, et al.. (2003). Measuring the Quality of Depression Care in a Large Integrated Health System. Medical Care. 41(5). 669–680. 92 indexed citations
15.
Goff, Donald, Leslie Leahy, Ileana Berman, et al.. (2001). A Placebo-Controlled Pilot Study of the Ampakine CX516 Added to Clozapine in Schizophrenia. Journal of Clinical Psychopharmacology. 21(5). 484–487. 167 indexed citations
16.
Herz, Lawrence, et al.. (1998). An Exploratory Haloperidol-Controlled Dose-Finding Study of Ziprasidone in Hospitalized Patients With Schizophrenia or Schizoaffective Disorder. Journal of Clinical Psychopharmacology. 18(4). 296–304. 148 indexed citations
17.
Orr, Scott P., Roger K. Pitman, Natasha B. Lasko, & Lawrence Herz. (1993). Psychophysiological assessment of posttraumatic stress disorder imagery in World War II and Korean combat veterans.. Journal of Abnormal Psychology. 102(1). 152–159. 174 indexed citations
18.
Herz, Lawrence, et al.. (1992). A Single-Case-Study Method for Treating Resistiveness in patients with Alzheimer's Disease. Psychiatric Services. 43(7). 720–724. 12 indexed citations
19.
Herz, Lawrence, et al.. (1990). Additional psychiatric illness by diagnostic interview schedule in male alcoholics. Comprehensive Psychiatry. 31(1). 72–79. 37 indexed citations
20.
Brown, William & Lawrence Herz. (1989). Response to Neuroleptic Drugs as a Device for Classifying Schizophrenia. Schizophrenia Bulletin. 15(1). 123–129. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tommi Tolmunen Breakdown of academic impact, for papers by Rudy Bowen Breakdown of academic impact, for papers by M. Ansseau Breakdown of academic impact, for papers by Felicity Ng Breakdown of academic impact, for papers by Jonna Perälä Breakdown of academic impact, for papers by Martin M. Katz Breakdown of academic impact, for papers by Chris C. Streeter Breakdown of academic impact, for papers by Arlette F. Buchmann Breakdown of academic impact, for papers by Federica Vellante Breakdown of academic impact, for papers by I Hui Lee
Rankless by CCL
2026